1 Mid-Cap Stock with Exciting Potential and 2 to Turn DownMid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
3 Cash-Heavy Stocks in the DoghouseA surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
3 Consumer Stocks with Questionable FundamentalsRetailers are evolving to meet the expectations of modern, tech-savvy shoppers. But many seem to be moving too slowly as their demand is lagging, causing the industry to underperform the market -
over the past six months, retail stocks have shed 13.6%. This drawdown was worse than the S&P 500’s 5.1% loss.
2 Cash-Heavy Stocks to Keep an Eye On and 1 to Brush OffCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear OfWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
1 Oversold Stock Ready to Bounce Back and 2 to Keep Off Your RadarRock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
2 Mid-Cap Stocks Worth Your Attention and 1 to Steer Clear OfMid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
3 Cash-Heavy Stocks That Concern UsA surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
1 Profitable Stock to Research Further and 2 to IgnoreNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
3 Volatile Stocks with Questionable FundamentalsA highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
1 Profitable Stock to Target This Week and 2 to QuestionWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Market-Beating Stocks for Long-Term InvestorsStocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
2 Profitable Stocks on Our Buy List and 1 to Think Twice AboutA company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
1 Cash-Producing Stock Worth Your Attention and 2 to Think Twice AboutA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Hated Stocks in the DoghouseHitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
3 Profitable Stocks in Hot WaterNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
3 Dawdling Stocks with Mounting ChallengesStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
3 Dawdling Stocks Facing HeadwindsStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
1 Profitable Stock to Target This Week and 2 to Approach with CautionWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Cash-Heavy Stocks Skating on Thin IceA cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
1 Profitable Stock on Our Watchlist and 2 to Be Wary OfA company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
3 Profitable Stocks with Mounting ChallengesWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Dawdling Stocks Walking a Fine LineA stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
1 Healthcare Stock Worth Your Attention and 2 to Turn DownPersonal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand.
The result? Over the past six months, the industry has tumbled by 11.7%. This performance was worse than the S&P 500’s 5.1% loss.
2 Unprofitable Stocks to Research Further and 1 to QuestionUnprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
2 Profitable Stocks with Solid Fundamentals and 1 to Approach with CautionA company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
3 Cash-Producing Stocks Walking a Fine LineA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
1 Hated Stock that Deserves Some Love and 2 to IgnoreWall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
3 Cash-Producing Stocks in the DoghouseA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Unprofitable Stocks with Questionable FundamentalsUnprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
3 Market-Beating Stocks with Solid FundamentalsStocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 to IgnoreThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Be Wary OfThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
1 Cash-Producing Stock to Own for Decades and 2 to Approach with CautionWhile strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
2 of Wall Street’s Favorite Stocks Worth Investigating and 1 to Brush OffWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
3 Value Stocks That Concern UsValue stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
3 Healthcare Stocks That Concern UsFrom novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 11.7%. This drawdown was worse than the S&P 500’s 5.2% decline.
2 Hated Stocks that Deserve a Second Chance and 1 to Think Twice AboutWall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
1 Volatile Stock to Target This Week and 2 to Keep Off Your RadarVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
1 Volatile Stock to Own for Decades and 2 to Keep Off Your RadarMarket swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions.
While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
3 Value Stocks Facing HeadwindsThe low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
3 of Wall Street’s Favorite Stocks Skating on Thin IceWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Domino's (NASDAQ:DPZ) Misses Q1 Sales TargetsFast-food pizza chain Domino’s (
NYSE:DPZ) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.5% year on year to $1.11 billion. Its GAAP profit of $4.33 per share was 6.3% above analysts’ consensus estimates.
Revvity (NYSE:RVTY) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds ExpectationsLife sciences company Revvity (
NYSE:RVTY) announced better-than-expected revenue in Q1 CY2025, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue guidance of $2.85 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.01 per share was 6.4% above analysts’ consensus estimates.
TransDigm (TDG): 3 Reasons We Love This StockTransDigm currently trades at $1,377 per share and has shown little upside over the past six months, posting a middling return of 2.8%. However, the stock is beating the S&P 500’s 5.4% decline during that period.
3 Reasons to Avoid PTLO and 1 Stock to Buy InsteadPortillo’s stock price has taken a beating over the past six months, shedding 20.5% of its value and falling to $10.59 per share. This might have investors contemplating their next move.
3 Reasons ACEL is Risky and 1 Stock to Buy InsteadAccel Entertainment trades at $10.28 per share and has stayed right on track with the overall market, losing 9.5% over the last six months while the S&P 500 is down 5.4%. This may have investors wondering how to approach the situation.
3 Reasons COHR is Risky and 1 Stock to Buy InsteadCoherent has gotten torched over the last six months - since October 2024, its stock price has dropped 33.4% to $64.20 per share. This might have investors contemplating their next move.
2 Reasons to Like ERII (and 1 Not So Much)Over the past six months, Energy Recovery’s shares (currently trading at $15.02) have posted a disappointing 16.5% loss while the S&P 500 was down 5.3%. This may have investors wondering how to approach the situation.
3 Reasons to Sell TDUP and 1 Stock to Buy InsteadThredUp has been on fire lately. In the past six months alone, the company’s stock price has rocketed 489%, reaching $4.20 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid QLYS and 1 Stock to Buy InsteadSince October 2024, Qualys has been in a holding pattern, posting a small return of 2.8% while floating around $125.31. However, the stock is beating the S&P 500’s 5.3% decline during that period.
3 Big Reasons to Love Semrush (SEMR)Semrush’s stock price has taken a beating over the past six months, shedding 20.1% of its value and falling to $10.33 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Braze (BRZE): Buy, Sell, or Hold Post Q4 Earnings?Since October 2024, Braze has been in a holding pattern, floating around $30.70.
3 Reasons KMT is Risky and 1 Stock to Buy InsteadKennametal’s stock price has taken a beating over the past six months, shedding 24.6% of its value and falling to $19.29 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Q4 Earnings Roundup: BlackLine (NASDAQ:BL) And The Rest Of The Finance and HR Software SegmentEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BlackLine (
NASDAQ:BL) and its peers.
Fastenal (FAST): Buy, Sell, or Hold Post Q1 Earnings?While the broader market has struggled with the S&P 500 down 5.3% since October 2024, Fastenal has surged ahead as its stock price has climbed by 6% to $81.29 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell AMPL and 1 Stock to Buy InsteadSince October 2024, Amplitude has been in a holding pattern, posting a small loss of 0.6% while floating around $8.96.
3 Reasons MDU is Risky and 1 Stock to Buy InsteadMDU Resources has gotten torched over the last six months - since October 2024, its stock price has dropped 42.8% to $16.95 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Sell JAZZ and 1 Stock to Buy InsteadJazz Pharmaceuticals currently trades at $109.85 per share and has shown little upside over the past six months, posting a small loss of 1.4%.
3 Reasons to Avoid DNOW and 1 Stock to Buy InsteadSince April 2020, the S&P 500 has delivered a total return of 92.4%. But one standout stock has nearly doubled the market - over the past five years, DistributionNOW has surged 162% to $15.52 per share. Its momentum hasn’t stopped as it’s also gained 29.5% in the last six months thanks to its solid quarterly results, beating the S&P by 34.9%.
Winners And Losers Of Q1: Churchill Downs (NASDAQ:CHDN) Vs The Rest Of The Consumer Discretionary StocksAs the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the consumer discretionary industry, including Churchill Downs (
NASDAQ:CHDN) and its peers.
Cracker Barrel (CBRL): Buy, Sell, or Hold Post Q4 Earnings?Over the last six months, Cracker Barrel shares have sunk to $42.74, producing a disappointing 14.4% loss - worse than the S&P 500’s 5.3% drop. This may have investors wondering how to approach the situation.
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The RestLet’s dig into the relative performance of Viatris (
NASDAQ:VTRS) and its peers as we unravel the now-completed Q4 generic pharmaceuticals earnings season.
3 Reasons to Sell MKC and 1 Stock to Buy InsteadMcCormick trades at $74.11 per share and has stayed right on track with the overall market, losing 5.4% over the last six months while the S&P 500 is down 5.4%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons GIII is Risky and 1 Stock to Buy InsteadAlthough the S&P 500 is down 5.4% over the past six months, G-III’s stock price has fallen further to $25.58, losing shareholders 18.3% of their capital. This may have investors wondering how to approach the situation.
A Look Back at Engineering and Design Services Stocks’ Q4 Earnings: EMCOR (NYSE:EME) Vs The Rest Of The PackLet’s dig into the relative performance of EMCOR (
NYSE:EME) and its peers as we unravel the now-completed Q4 engineering and design services earnings season.
Engineered Components and Systems Q4 Earnings: ESCO (NYSE:ESE) is the Best in the BizAs the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the engineered components and systems industry, including ESCO (
NYSE:ESE) and its peers.
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers StocksQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (
NASDAQ:OMCL) and the best and worst performers in the healthcare technology for providers industry.
Inspired (INSE): Buy, Sell, or Hold Post Q4 Earnings?Inspired’s stock price has taken a beating over the past six months, shedding 25.2% of its value and falling to $6.81 per share. This might have investors contemplating their next move.
3 Reasons to Avoid AMRC and 1 Stock to Buy InsteadShareholders of Ameresco would probably like to forget the past six months even happened. The stock dropped 66.9% and now trades at $10.51. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Avoid FLEX and 1 Stock to Buy InsteadFlex has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $34.65.
3 Reasons We’re Fans of BellRing Brands (BRBR)BellRing Brands currently trades at $75.92 and has been a dream stock for shareholders. It’s returned 338% since April 2020, blowing past the S&P 500’s 92.4% gain. The company has also beaten the index over the past six months as its stock price is up 16.6% thanks to its solid quarterly results.
Q4 Earnings Highs And Lows: Sleep Number (NASDAQ:SNBR) Vs The Rest Of The Home Furniture Retailer StocksAs the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the home furniture retailer industry, including Sleep Number (
NASDAQ:SNBR) and its peers.
Online Marketplace Stocks Q4 Teardown: CarGurus (NASDAQ:CARG) Vs The RestAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at online marketplace stocks, starting with CarGurus (
NASDAQ:CARG).
Firing on All Cylinders: FOX (NASDAQ:FOXA) Q4 Earnings Lead the WayThe end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how broadcasting stocks fared in Q4, starting with FOX (
NASDAQ:FOXA).
